HealthSouth Corporation (HLS) Rating Increased to Hold at Zacks Investment Research

HealthSouth Corporation (NYSE:HLS) was upgraded by Zacks Investment Research from a “sell” rating to a “hold” rating in a report released on Wednesday.

According to Zacks, “HEALTHSOUTH Corp. is the one of the nation’s largest providers of outpatient surgery and rehabilitative healthcare services. The company provides these services through its national network of inpatient and outpatient healthcare facilities, including inpatient and outpatient rehabilitation facilities, outpatient surgery centers, diagnostic centers, occupational medicine centers, medical centers and other healthcare facilities. “

HLS has been the topic of a number of other reports. Stephens began coverage on HealthSouth Corporation in a report on Thursday, August 31st. They issued an “overweight” rating and a $53.00 price target on the stock. Royal Bank Of Canada reissued a “buy” rating and issued a $55.00 price target on shares of HealthSouth Corporation in a report on Wednesday, September 6th. KeyCorp reissued a “hold” rating on shares of HealthSouth Corporation in a report on Thursday, September 7th. ValuEngine raised HealthSouth Corporation from a “hold” rating to a “buy” rating in a report on Friday, July 7th. Finally, BidaskClub cut HealthSouth Corporation from a “hold” rating to a “sell” rating in a report on Thursday, July 13th. Two equities research analysts have rated the stock with a sell rating, five have assigned a hold rating and four have issued a buy rating to the stock. The stock has a consensus rating of “Hold” and an average target price of $50.38.

HealthSouth Corporation (NYSE:HLS) last posted its quarterly earnings results on Monday, July 31st. The company reported $0.71 EPS for the quarter, topping the Zacks’ consensus estimate of $0.68 by $0.03. HealthSouth Corporation had a return on equity of 25.07% and a net margin of 6.70%. The company had revenue of $981.30 million for the quarter, compared to analysts’ expectations of $976.46 million. During the same period in the previous year, the firm earned $0.69 EPS. The firm’s revenue was up 6.6% compared to the same quarter last year.

COPYRIGHT VIOLATION NOTICE: “HealthSouth Corporation (HLS) Rating Increased to Hold at Zacks Investment Research” was first published by TrueBlueTribune and is the property of of TrueBlueTribune. If you are viewing this piece on another domain, it was stolen and reposted in violation of United States & international copyright and trademark legislation. The original version of this piece can be accessed at https://www.truebluetribune.com/2017/10/13/healthsouth-corporation-hls-rating-increased-to-hold-at-zacks-investment-research.html.

In related news, CEO Mark J. Tarr sold 22,625 shares of the company’s stock in a transaction on Monday, August 7th. The stock was sold at an average price of $43.00, for a total transaction of $972,875.00. Following the completion of the sale, the chief executive officer now directly owns 283,134 shares in the company, valued at approximately $12,174,762. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. Corporate insiders own 1.60% of the company’s stock.

Several hedge funds and other institutional investors have recently modified their holdings of the stock. Vanguard Group Inc. lifted its stake in shares of HealthSouth Corporation by 4.6% during the 2nd quarter. Vanguard Group Inc. now owns 7,532,456 shares of the company’s stock worth $364,571,000 after purchasing an additional 328,081 shares during the last quarter. William Blair Investment Management LLC lifted its stake in shares of HealthSouth Corporation by 13.9% during the 2nd quarter. William Blair Investment Management LLC now owns 4,302,756 shares of the company’s stock worth $208,253,000 after purchasing an additional 525,767 shares during the last quarter. State Street Corp lifted its stake in shares of HealthSouth Corporation by 7.5% during the 2nd quarter. State Street Corp now owns 3,129,781 shares of the company’s stock worth $151,479,000 after purchasing an additional 219,306 shares during the last quarter. Voya Investment Management LLC lifted its stake in shares of HealthSouth Corporation by 4.4% during the 2nd quarter. Voya Investment Management LLC now owns 1,621,585 shares of the company’s stock worth $78,485,000 after purchasing an additional 68,486 shares during the last quarter. Finally, Bank of New York Mellon Corp lifted its stake in shares of HealthSouth Corporation by 1.6% during the 2nd quarter. Bank of New York Mellon Corp now owns 1,458,636 shares of the company’s stock worth $70,597,000 after purchasing an additional 23,480 shares during the last quarter. Hedge funds and other institutional investors own 93.05% of the company’s stock.

HealthSouth Corporation Company Profile

HealthSouth Corporation (HealthSouth) is a provider of post-acute healthcare services, offering both facility-based and home-based post-acute services in 35 states and Puerto Rico through its network of inpatient rehabilitation hospitals, home health agencies and hospice agencies. The Company manages its operations through segments, including inpatient rehabilitation, and home health and hospice.

Analyst Recommendations for HealthSouth Corporation (NYSE:HLS)

Receive News & Ratings for HealthSouth Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthSouth Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply